blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0813867

EP0813867 - Retroviral protease inhibitors [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  07.04.2006
Database last updated on 16.07.2024
Most recent event   Tooltip08.06.2007Change - lapse in a contracting state
State(s) deleted from list of lapses: GB
published on 11.07.2007  [2007/28]
Applicant(s)For all designated states
Monsanto Company
800 North Lindbergh Boulevard
St. Louis, Missouri 63167 / US
For all designated states
G.D. Searle & Co.
5200 Old Orchard Road
Skikie IL 60077 / US
[N/P]
Former [2005/22]For all designated states
MONSANTO COMPANY
800 North Lindbergh Boulevard
St. Louis, Missouri 63167 / US
For all designated states
G.D. Searle & Co.
5200 Old Orchard Road
Skokie, Illinois 60077 / US
Former [1997/52]For all designated states
MONSANTO COMPANY
800 North Lindbergh Boulevard
St. Louis, Missouri 63167 / US
For all designated states
G.D. Searle & Co.
5200 Old Orchard Road
Skokie Illinois 60077 / US
Inventor(s)01 / Clare, Michael
5154 West Brown Street
Skokje, Illinois 60077 / US
02 / Freskos, John Nicholas
7572 York
Clayton, Missouri 63105 / US
03 / Heintz, Robert Martin
603 Nancy Place
Ballwin, Missouri 63021 / US
04 / Decrescenzo, Gary Anthony
536 Schrader Farm Drive
St. Peters, Missouri 63376 / US
05 / Getman, Daniel Paul
66 Sunny Hill Ct.
Chesterfield, Mo. 63107 / US
06 / Lin, Ko-Chung
12790 Polo Parc Drive
St. Louis, Missouri 63146 / US
07 / Mueller, Richard August
562 Stonegate Terrace
Glencoe, Illinois 60022 / US
08 / Talley, John Jeffrey
1510 Amisk Court
Chesterfield, Missouri 63017 / US
09 / Sun, Eric Tak On
7614 Palmalla Drive Apartment 58
San Diego, CA 92212 / US
10 / Reed, Kathryn Lea
1103 Claytonia Terrace
Richmond Heights, Missouri 63117 / US
11 / Vasquez, Michael Lawrence
233 Saratoge Court
Gurnee, Illinois 60031 / US
[1997/52]
Representative(s)Colens, Alain M.G.M.
Office Hanssens SPRL
Rue Franz Merjay 21
1050 Bruxelles / BE
[N/P]
Former [2005/20]Colens, Alain
Office Hanssens Colens Square Marie Louise 40 Bte 19
1000 Bruxelles / BE
Former [2002/37]Colens, Alain
Rue Franz Merjay, 21
1050 Bruxelles / BE
Former [1997/52]Bosch, Henry, et al
Monsanto Services International S.A. Patent Department Avenue de Tervuren 270/272 Letter Box No. 21
1150 Brussels / BE
Application number, filing date97105350.918.11.1991
[1997/52]
Priority number, dateUS1990061521019.11.1990         Original published format: US 615210
[1997/52]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0813867
Date:29.12.1997
Language:EN
[1997/52]
Type: A3 Search report 
No.:EP0813867
Date:01.04.1998
[1998/14]
Type: B1 Patent specification 
No.:EP0813867
Date:01.06.2005
Language:EN
[2005/22]
Search report(s)(Supplementary) European search report - dispatched on:EP12.02.1998
ClassificationIPC:A61K31/17, A61K31/47, A61K31/44, A61K31/535, A61K31/505, A61K31/34, A61K31/415, A61K31/495, A61K31/215, A61K31/18, A61K31/325, A61K31/40, A61K31/195
[1998/12]
CPC:
C07K5/06191 (EP); A61K31/17 (EP); A61K31/195 (EP);
A61K31/197 (EP); A61K31/216 (EP); A61K31/27 (EP);
A61K31/47 (EP); A61K31/4709 (EP); A61K31/496 (EP);
A61K31/5377 (EP); A61P31/12 (EP); A61P37/04 (EP);
A61P43/00 (EP); C07C213/00 (EP); C07C213/02 (EP);
C07C213/08 (EP); C07C271/20 (EP); C07C271/22 (EP);
C07C275/14 (EP); C07C275/18 (EP); C07C275/22 (EP);
C07C275/24 (EP); C07C275/28 (EP); C07C311/47 (EP);
C07C317/44 (EP); C07C317/50 (EP); C07C323/60 (EP);
C07C329/06 (EP); C07C335/08 (EP); C07C335/12 (EP);
C07D213/81 (EP); C07D215/48 (EP); C07D215/50 (EP);
C07D215/54 (EP); C07D217/26 (EP); C07D235/06 (EP);
C07D235/24 (EP); C07D239/38 (EP); C07D241/44 (EP);
C07D295/13 (EP); C07D295/15 (EP); C07D307/85 (EP);
C07D401/12 (EP); C07K5/0207 (EP); C07K5/021 (EP);
C07K5/06026 (EP); C07K5/06139 (EP); A61K38/00 (EP);
C07B2200/07 (EP); C07C2601/02 (EP); C07C2601/04 (EP);
C07C2601/08 (EP); C07C2601/14 (EP) (-)
C-Set:
C07C213/00, C07C215/08 (EP);
C07C213/02, C07C215/28 (EP);
C07C213/08, C07C215/28 (EP)
Former IPC [1997/52]A61K31/17, A61K31/47, A61K31/44, A61K31/535, A61K31/505, A61K31/34, A61K31/415, A61K31/495, A61K31/215, A61K31/18, A61K31/40
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1997/52]
TitleGerman:Retrovirusprotease Inhibitoren[1997/52]
English:Retroviral protease inhibitors[1997/52]
French:Inhibiteurs de protéases rétrovirales[1997/52]
Examination procedure28.09.1998Examination requested  [1998/52]
01.03.2002Despatch of a communication from the examining division (Time limit: M06)
06.09.2002Reply to a communication from the examining division
16.06.2003Despatch of a communication from the examining division (Time limit: M04)
03.12.2003Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
09.02.2004Reply to a communication from the examining division
19.10.2004Date of oral proceedings
04.11.2004Minutes of oral proceedings despatched
16.11.2004Communication of intention to grant the patent
25.03.2005Fee for grant paid
25.03.2005Fee for publishing/printing paid
Parent application(s)   TooltipEP92901068.4  / EP0558630
Opposition(s)02.03.2006No opposition filed within time limit [2006/21]
Request for further processing for:09.02.2004Request for further processing filed
09.02.2004Full payment received (date of receipt of payment)
Request granted
23.02.2004Decision despatched
Fees paidRenewal fee
16.04.1997Renewal fee patent year 03
16.04.1997Renewal fee patent year 04
16.04.1997Renewal fee patent year 05
16.04.1997Renewal fee patent year 06
15.01.1998Renewal fee patent year 07
20.01.1999Renewal fee patent year 08
04.11.1999Renewal fee patent year 09
03.11.2000Renewal fee patent year 10
22.11.2001Renewal fee patent year 11
25.11.2002Renewal fee patent year 12
21.11.2003Renewal fee patent year 13
30.03.2005Renewal fee patent year 14
Penalty fee
Additional fee for renewal fee
30.11.199707   M06   Fee paid on   15.01.1998
30.11.199808   M06   Fee paid on   20.01.1999
30.11.200414   M06   Fee paid on   30.03.2005
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipLU30.11.2005
[2007/28]
Former [2007/17]GB18.11.2005
LU30.11.2005
Documents cited:Search[A]EP0159156  (SQUIBB & SONS INC [US]) [A] 1-26* the whole document, especially pages 32-34 *;
 [A]GB2200115  (SANDOZ LTD) [A] 1-26 * the whole document *;
 [A]FR2620451  (SANDOZ SA [CH]) [A] 1-26 * the whole document, especially page 26 last paragraph, page 27 and claim 9 *;
 [A]WO8910920  (UPJOHN CO [US]) [A] 1-26 * the whole document *;
 [A]EP0365992  (ABBOTT LAB [US]) [A] 1-26 * page 3, line 7 - line 8 * * page 5 - page 7 * * page 8, line 1 - line 21 * * page 14, line 35 - line 42 * * page 134, line 11 - line 23 *;
 [A]  - SALI ET AL., "High-resolution X-ray diffraction study of the complex between endothiapepsin and an oligopeptide inhibitor: the analysis of the inhibitor binding and description of the rigid body shift in the enzyme", EMBO J., (1988), vol. 8, no. 8, pages 2179 - 2188, XP002052826 [A] 1-26 * the whole document *
 [AD]  - ROBERTS N A ET AL, "RATIONAL DESIGN OF PEPTIDE-BASED HIV PROTEINASE INHIBITORS", SCIENCE, (19900420), vol. 248, no. 4953, pages 358 - 361, XP002024830 [AD] 1-26 * the whole document *

DOI:   http://dx.doi.org/10.1126/science.2183354
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.